Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01821768 · ClinicalTrials.gov registry record · NA
Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT01821768 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 69 participants.
The verdict
NCT01821768, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
This randomized clinical trial studies two different tests that are currently being used to detect the spread of breast cancer to the lymph nodes under the arm in candidates for breast conservation therapy. The two tests are sentinel lymph node biopsy (SLNB) and axillary ultrasound. The current standard of care is sentinel lymph node biopsy, which is a surgical procedure. Axillary ultrasound (AUS) may be just as good as SLNB for detecting the spread of cancer but without the surgical risks.
Interventions
- PROCEDURE Sentinel Lymph Node Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2013-04-04 |
| Est. Completion | 2018-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01821768
The ClinicalTrials.gov registry entry for NCT01821768 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sentinel Lymph Node Biopsy is the first listed.
NCT01821768 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01821768 about?
NCT01821768 is a clinical study titled "Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy". This randomized clinical trial studies two different tests that are currently being used to detect the spread of breast cancer to the lymph nodes under the arm in candidates for breast conservation therapy. The two tests are sentinel lymph node biopsy (SLNB) and axillary ultrasound. The current stan...
What is the current status of trial NCT01821768?
This trial is currently terminated. It is a NA study. The enrollment target is 69 participants. The study started on 2013-04-04. Estimated completion is 2018-07-26.
What interventions are being tested in trial NCT01821768?
The interventions under investigation include: Sentinel Lymph Node Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01821768?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.